By using serum samples from a DENV-endemic area, we demonstrated that infection-enhancing activity which was determined only by using FcγR-expressing cells hampers neutralizing activity that was determined using FcγR-negative BHK cells. The gene discussed is FCGR2A; the disease is infection.